期刊文献+

血清PSA测定与前列腺癌病理组织学类型关系的研究 被引量:4

Relationship between serum PSA level and pathdogical histology type of prostate cancer
原文传递
导出
摘要 目的研究血清PSA水平与前列腺癌病理组织学类型的关系,以提高前列腺癌的早期诊断水平。方法选择经手术证实的前列腺癌(PCa)组50例和前列腺增生(BPH)组50例,术前均测定血清TPSA、FPSA和P(V)、RI水平并与病理组织学类型进行比较相关分析,采用SPSS 10.0统计学处理。结果PCa组与BPH组比较,血清中TPSA,FPSA,F/T比值,PSAD和P(V)水平两组差异有显著性意义(P<0.01)。低分化癌组与高分化癌相比较:血清TPSA、FPSA、PSAD和RI水平两组差异有显著性差异(P<0.05)。比较分析表明血清TPSA、FPSA、PSAD和RI水平与前列腺癌病理组织学类型密切相关(r≈0.4),而F/T比值和P(V)无相关性。结论PSA是前列腺早期诊断和预后判断的可靠指标。 Objective To study the relationship of the serum PSA level and the pathological histology type of prostate cancer so as to increases the early diagnosis of prostatic canaer. Methods choose 50 cases in PCa group and 50 cases in BPH group confirmed by pathological histology. Before operation the serum level of TPSA, FPSA and P(V), were compared with the pathological histology type by means of spss 10.0 statisties analysis. Results There is significant difference of TPSA, FPSA, ratio of F/T, PSAD and P(V) level between PCa group and BPH group(P〈0.04). There is significant difference of TPSA, FPSA, PSAD and RI levels between lower grade cancer group and higher grade one (P〈0.05). There is close relation between the serum TPSA, FPSA, PSAD and RI levels and the pathological histology type of PCa by means of spearman rank correlation but there is no correlation between the ratio of F/T and P(V). Conclusion PSA is a reliable predictor for early diagnosis and of prognosis of PCa.
出处 《中国男科学杂志》 CAS CSCD 2006年第8期45-48,共4页 Chinese Journal of Andrology
关键词 前列腺特异抗原 前列腺肿瘤/病理学 组织学 prostate-specific agtigen prostatic neoplasms/pathology, histology
  • 相关文献

参考文献6

  • 1Oesterling JE.Tacobson SJ.Klee GG,et al.Free,Complexed and total serum prostate specific antigen:the establishment of appropriate reference ranges for their concentions and ratios.J Urol 1995; 154(3):1090-1095
  • 2周利群,陈为民,那彦群,黄有媛,冯陶,郝金瑞,潘柏年,薛兆英,顾方六,郭应禄.良性前列腺增生患者血清PSA与年龄变化的关系[J].中华泌尿外科杂志,2002,23(5):293-295. 被引量:38
  • 3Hudson MA,Bahnson RR,Catalona WJ.Clinical use of prostate specific antigen in patients with prostate cancer.J Urol 1989; 142(4):1011-1017
  • 4Ferro MA,Barnes I,Roberts JB,et al.Tumour markers in prostatic carcinoma:a comparison of prostate specific antigen with acid Phosphatase.Br J Urol 1987; 60(1):69-73
  • 5Pannek J,Rittenhouse HG,Chan DW,et al.The use of precent free prostate specific antigen for staging clinically localized prostate cancer.J Urol 1998; 159(4):1238-1242
  • 6Carter HB.Pearson JD.Metter EJ,et al.Longitudinal evaluation of prostate specific antigen levels in men with and without prostate diseases.JAMA 1992; 267(16):2215-2220

二级参考文献8

  • 1Carter HB,Pearson JD,Metter EJ,et al.Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease[].The Journal of The American Medical Association.1992
  • 2Christensson A,Bjork T,Nilsson O,et al.Serum prostate specific antigen complexed to alpha1 - antichymotrypsin as an indicator of prostate cancer[].Journal d Urologie.1993
  • 3Oesterling JE,Jacobsen SJ,Chute CG,et al.Serum prostate-specific antigen in a commuinity-based population of healthy men[].The Journal of The American Medical Association.1993
  • 4Collins GN,Martin PJ,Wynn-Davies A,et al.The effect of dig-ital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free- to- total prostate specific antigen ratio in clinical practice[].Journal d Urologie.1997
  • 5Robles JM,Morell AR,Redorta JP,et al.Clinical behavior of prostate specific antigen and prostatic acid phosphotase: a comparative study[].European Urology.1988
  • 6Glenski WJ,Malek RS,Myrtle JF,et al.Sustained, sunstantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario[].Mayo Clinic Proceedings.1992
  • 7Brawer MK.Prostatic intraepithelial neoplasia and prostatic-specific antigen[].Urology.1989
  • 8Benson MC,Whang IS,Pantuck A,et al.Prostate specific antigen density: a means of distinguishing benign prostatic hypertraphy and prostate cancer[].Journal d Urologie.1992

共引文献37

同被引文献47

  • 1庄仁汉,黎明,林炳森,蔡发成.经尿道电切结合间歇性内分泌治疗晚期前列腺癌20例报告[J].临床泌尿外科杂志,2006,21(6):432-433. 被引量:6
  • 2刘欣,唐杰,张舜欣,杨敬春.PSA正常前列腺占位的诊断[J].中国医学影像技术,2007,23(5):752-754. 被引量:5
  • 3陈伟杰,吴宗林,唐炯.血清PSA正常的进展型前列腺癌2例报告[J].中华男科学杂志,2007,13(6):559-560. 被引量:3
  • 4Pelzer A E,Volgger H,Bektic J,et al.The effect of percentage free prostate-specific antigen (PSA) level on the prostate cancer detection rate in a screening population with low PSA levels.BJU Int,2005,96(7):995-998.
  • 5Bangma CH,Kranse R,Blijenberg BG,et al.The value of screening tests in the detection of prostate cancer.Part I:Results of a retrospective evaluation of 1726 men.J Urol,1995,46(6):773-778.
  • 6Thompson M,Pauler DK,Goodman PJ,et al.Prevalence of prostate cancer among men with a prostate-specific antigen level 《 or =4.0 ng per milliliter.N Engl J Med,2004,350(22):2239-2248.
  • 7Sella A,Konichezky M,Flex D,et al.Low PSA metastatic androgen-independent prostate cancer.Eur Urol,2000,38(3):250-254.
  • 8Nishio R,Furuya Y,Nagakawa O,et al.Metastatic prostate cancer with normal level of serum prostate-specific antigen.Int Urol Nephrol,2003,35(2):189-192.
  • 9Datta MW,Dhir R,Dobbin K,et al.Prostate cancer in patients with screening serum prostate specific antigen values less than 4.0ng/ml:results from the cooperative prostate cancer tissue resource.J Urol,2005,173(5):1546-1551.
  • 10Pepe P,Panella P,Savoca F,et al.Prevalence and clinical significance of prostate cancer among 12,682 men with normal digital rectal examination,low PSA levels(《 or =4 ng/ml) and percent free PSA cutoff values of 15 and 20%.Urol Int,2007,78(4):308-312.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部